2 7 a b s t r a c t 28 Alginate microbeads and microcapsules are presently under evaluation for future cell-based therapy. 29 Defining their inflammatory properties with regard to humans is therefore essential. A lepirudine-based 30 human whole blood model was used as an inflammation predictor by measuring complement and leuko- 31 cyte stimulation. Alginate microbeads were complement-compatible since they did not activate comple- 32 ment as measured by the soluble terminal complement complex (sTCC), Bb or the anaphylatoxins C3a 33 and C5a. In addition, alginate microbeads were free of surface adherent leukocytes. In contrast, microcap- 34 sules containing poly-L-lysine (PLL) induced elevated levels of sTCC, Bb, C3a and C5a, surface active C3 35 convertase and leukocyte adhesion. The soluble PLL induced elevated levels of sTCC and up-regulated leu- 36 kocyte CD11b expression. PMCG microcapsules containing poly(methylene-co-guanidine) complexed 37 with sodium alginate and cellulose sulfate triggered a fast sTCC response and C3 deposition. The PMCG Cell-based therapy using alginate containing microspheres has 48 been suggested for the treatment of hormone deficiencies [1] as 49 well as brain cancer [2] . The long-term function in experimental 50 animals is, however, often hampered by overgrowth reactions 51 leading to reduced graft performance [1] . The factors contributing 52 to graft failure of the encapsulated cells are only partly understood. 53 There is currently a need for experimental models relevant to hu- inflammatory cells [4] . In this way it has been possible to study 73 the mutual interactions between complement and leukocytes, as 74 well as between other branches of the inflammatory network. 75 Complement is a major pro-inflammatory system that acts up- Single experiments for each blood donor were performed as 205 previous described using lepirudin (50 lg ml with saline at all time points (Fig. 1B-D) . The APA and AP micro-301 capsules showed a time-dependent increase in sTCC (Fig. 1B-D) .
302
The PMCG microcapsules induced a rapid initial increase in sTCC, 303 detected after 30 min (Fig. 1B) . This was followed by a slower in- over time ( Fig. 2C and D) , with a significant (P < 0.05) difference 321 at 360 min (Fig. 2D) . The highest concentration of Bb was found 322 in samples containing APA and AP microcapsules. The increase 323 was significant for AP at 120 and 360 min (Fig. 2C) , and for APA 324 at 360 min (Fig. 2D) . A non-significant elevation of Bb was found 325 in the samples incubated with PMCG microcapsules for 30 min 326 (Fig. 2B) . The early induction at 30 min was followed by an evi-327 dent and significant (P < 0.05) increase after 120 min (Fig. 2C ).
328
Interestingly, the amount of Bb was not further increased by 329 the PMCG microcapsules at 360 min (Fig. 2D) . The saline control, 330 however, showed a steady increase, which resulted in similar Bb 331 amounts for the PMCG microcapsules and saline control after 332 360 min (Fig. 2D) . The kinetics were significantly different (P < 0.0001) for each addi-339 tive (Fig. 3A) . At the specific time points only a few of the additives C3a (Fig. 3B-D) . The PMCG microcapsules initially gave a slight ele-347 vation of C3a (Fig. 3B) . However, after 120 and 360 min the PMCG 348 microcapsules resulted in significantly (P < 0.05) lower amounts of 349 C3a than saline (Fig. 3A-D) . The dissolved UP-MVG alginate in-350 duced a slight but significant (P < 0.05) increase in C3a after 351 30 min (Fig. 3B ), but after 120 and 360 min the amount of C3a 352 was lower than for the saline control ( Fig. 3C and D [23] .
356
The kinetics of C5a production were also significantly different all time points and for AP at 120 and 360 min (Fig. 4B-D) . PMCG 366 microcapsules initially gave a modest, but statistically significant 367 (P < 0.05), increase in C5a (Fig. 4B) . Over time the PMCG microcap-368 sules resulted in lower C5a amounts compared with the saline con-369 trol, with a significant (P < 0.05) difference after 360 min (Fig. 4D) . for Ca/Ba beads (Fig. 5A) and APA (Fig. 5B ) and AP microcapsules 381 (Fig. 5C ). In contrast, the PMCG microcapsules showed pro-382 nounced staining at 30 min (Fig. 5D) . The C3 staining on the 383 PMCG microcapsules revealed surface irregularities and ruptures 384 (Fig. 5D) . No further increase in C3 staining was observed for 385 the PMCG microcapsules after 120 (Fig. 5H ) and 360 min 386 (Fig. 5L) . The surfaces of the APA (Fig. 5F and J) and AP microcap- Leukocyte adherence on microspheres was evaluated after incu-422 bation in whole blood for 3 h (Fig. 6C-J) . Leukocytes did not adhere 423 to the Ca/Ba beads (Fig. 6C ) or Ba beads (Fig. 6D) . However, adher-424 ent leukocytes were found on the surface of APA (Fig. 6E and F (Fig. 7A) . The polycation PMCG resulted in increased sTCC 442 formation at the highest dose (1000 lg ml -1 ), whereas addition 443 of CS showed a weak inhibitory effect (Fig. 7A) . In contrast, CS gave (Fig. 7B) . Increased granulocyte CD11b expression was also 446 found after addition of PLL (Fig. 7B) , although with lower potency 447 than CS. In contrast, dissolved PMCG showed a slight dose-depen-448 dent reduction in CD11b expression in both granulocytes (Fig. 7B ) 449 and monocytes (Fig. 7C) . PLL was a more potent inducer of CD11b 450 expression than CS in monocytes (Fig. 7C) . It is important to stress The C3 protein in its native form has a molecular weight of 481 185 kDa, thus it should be able to diffuse into the alginate matrix.
482
Penetration of C3 was found in the alginate microbeads to variable 483 depths of 10-125 lm (Fig. A1) In contrast to the alginate microbeads, the APA and AP micro- 
